Barriers for orally inhaled therapeutic antibodies
Description
INTRODUCTION: Respiratory diseases represent a worldwide health issue. The recent Sars-CoV-2 pandemic, the burden of lung cancer and inflammatory respiratory diseases urge for the development of innovative therapeutic solutions. In this context
